nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—CYP3A4—prostate cancer	0.299	1	CbGaD
Sufentanil—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0942	0.207	CbGbCtD
Sufentanil—CYP3A4—Bicalutamide—prostate cancer	0.0495	0.109	CbGbCtD
Sufentanil—CYP3A4—Estramustine—prostate cancer	0.046	0.101	CbGbCtD
Sufentanil—CYP3A4—Flutamide—prostate cancer	0.041	0.09	CbGbCtD
Sufentanil—CYP3A4—Abiraterone—prostate cancer	0.041	0.09	CbGbCtD
Sufentanil—CYP3A4—Cabazitaxel—prostate cancer	0.0303	0.0666	CbGbCtD
Sufentanil—CYP3A4—Estrone—prostate cancer	0.0296	0.0651	CbGbCtD
Sufentanil—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0264	0.058	CbGbCtD
Sufentanil—CYP3A4—Conjugated Estrogens—prostate cancer	0.0194	0.0426	CbGbCtD
Sufentanil—CYP3A4—Mitoxantrone—prostate cancer	0.0176	0.0387	CbGbCtD
Sufentanil—CYP3A4—Estradiol—prostate cancer	0.017	0.0374	CbGbCtD
Sufentanil—CYP3A4—Prednisone—prostate cancer	0.0146	0.0321	CbGbCtD
Sufentanil—CYP3A4—Etoposide—prostate cancer	0.0111	0.0244	CbGbCtD
Sufentanil—CYP3A4—Docetaxel—prostate cancer	0.0102	0.0223	CbGbCtD
Sufentanil—CYP3A4—Doxorubicin—prostate cancer	0.00758	0.0166	CbGbCtD
Sufentanil—Alfentanil—CYP3A5—prostate cancer	0.00129	0.511	CrCbGaD
Sufentanil—Chills—Goserelin—prostate cancer	0.000594	0.0037	CcSEcCtD
Sufentanil—Vomiting—Flutamide—prostate cancer	0.000593	0.0037	CcSEcCtD
Sufentanil—Pruritus—Degarelix—prostate cancer	0.000592	0.00369	CcSEcCtD
Sufentanil—Arrhythmia—Goserelin—prostate cancer	0.000592	0.00369	CcSEcCtD
Sufentanil—Rash—Nilutamide—prostate cancer	0.000591	0.00368	CcSEcCtD
Sufentanil—Dermatitis—Nilutamide—prostate cancer	0.00059	0.00368	CcSEcCtD
Sufentanil—Rash—Flutamide—prostate cancer	0.000588	0.00367	CcSEcCtD
Sufentanil—Dermatitis—Flutamide—prostate cancer	0.000588	0.00366	CcSEcCtD
Sufentanil—Headache—Nilutamide—prostate cancer	0.000587	0.00366	CcSEcCtD
Sufentanil—Arrhythmia—Conjugated Estrogens—prostate cancer	0.000586	0.00365	CcSEcCtD
Sufentanil—Headache—Flutamide—prostate cancer	0.000584	0.00364	CcSEcCtD
Sufentanil—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000582	0.00363	CcSEcCtD
Sufentanil—Hypersensitivity—Cabazitaxel—prostate cancer	0.000581	0.00362	CcSEcCtD
Sufentanil—Erythema—Goserelin—prostate cancer	0.000576	0.00359	CcSEcCtD
Sufentanil—Erythema—Conjugated Estrogens—prostate cancer	0.000571	0.00356	CcSEcCtD
Sufentanil—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.00056	0.00349	CcSEcCtD
Sufentanil—Cardiac arrest—Etoposide—prostate cancer	0.000559	0.00349	CcSEcCtD
Sufentanil—Feeling abnormal—Bicalutamide—prostate cancer	0.000557	0.00347	CcSEcCtD
Sufentanil—Alfentanil—CYP3A4—prostate cancer	0.000557	0.221	CrCbGaD
Sufentanil—Nausea—Nilutamide—prostate cancer	0.000557	0.00347	CcSEcCtD
Sufentanil—Injection site pain—Epirubicin—prostate cancer	0.000556	0.00347	CcSEcCtD
Sufentanil—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000555	0.00346	CcSEcCtD
Sufentanil—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000555	0.00346	CcSEcCtD
Sufentanil—Nausea—Flutamide—prostate cancer	0.000554	0.00345	CcSEcCtD
Sufentanil—Dizziness—Degarelix—prostate cancer	0.000553	0.00345	CcSEcCtD
Sufentanil—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000551	0.00344	CcSEcCtD
Sufentanil—Body temperature increased—Bicalutamide—prostate cancer	0.000535	0.00333	CcSEcCtD
Sufentanil—Vomiting—Degarelix—prostate cancer	0.000532	0.00332	CcSEcCtD
Sufentanil—Rash—Degarelix—prostate cancer	0.000528	0.00329	CcSEcCtD
Sufentanil—Dermatitis—Degarelix—prostate cancer	0.000527	0.00329	CcSEcCtD
Sufentanil—Headache—Degarelix—prostate cancer	0.000524	0.00327	CcSEcCtD
Sufentanil—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000523	0.00326	CcSEcCtD
Sufentanil—Dizziness—Cabazitaxel—prostate cancer	0.000521	0.00325	CcSEcCtD
Sufentanil—Urinary tract disorder—Estradiol—prostate cancer	0.000518	0.00323	CcSEcCtD
Sufentanil—Injection site pain—Doxorubicin—prostate cancer	0.000515	0.00321	CcSEcCtD
Sufentanil—Urethral disorder—Estradiol—prostate cancer	0.000515	0.00321	CcSEcCtD
Sufentanil—Vomiting—Cabazitaxel—prostate cancer	0.000501	0.00312	CcSEcCtD
Sufentanil—Bronchospasm—Etoposide—prostate cancer	0.0005	0.00312	CcSEcCtD
Sufentanil—Euphoric mood—Prednisone—prostate cancer	0.000499	0.00311	CcSEcCtD
Sufentanil—Hypersensitivity—Bicalutamide—prostate cancer	0.000498	0.00311	CcSEcCtD
Sufentanil—Bradycardia—Mitoxantrone—prostate cancer	0.000498	0.0031	CcSEcCtD
Sufentanil—Hypertension—Goserelin—prostate cancer	0.000498	0.0031	CcSEcCtD
Sufentanil—Nausea—Degarelix—prostate cancer	0.000497	0.0031	CcSEcCtD
Sufentanil—Headache—Cabazitaxel—prostate cancer	0.000494	0.00308	CcSEcCtD
Sufentanil—Pruritus—Bicalutamide—prostate cancer	0.000479	0.00298	CcSEcCtD
Sufentanil—Confusional state—Goserelin—prostate cancer	0.000474	0.00296	CcSEcCtD
Sufentanil—Fentanyl—CYP3A5—prostate cancer	0.000471	0.187	CrCbGaD
Sufentanil—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.000471	0.00294	CcSEcCtD
Sufentanil—Chills—Estradiol—prostate cancer	0.000471	0.00294	CcSEcCtD
Sufentanil—Anaphylactic shock—Goserelin—prostate cancer	0.000471	0.00293	CcSEcCtD
Sufentanil—Nausea—Cabazitaxel—prostate cancer	0.000468	0.00292	CcSEcCtD
Sufentanil—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.000466	0.0029	CcSEcCtD
Sufentanil—Tachycardia—Goserelin—prostate cancer	0.000459	0.00286	CcSEcCtD
Sufentanil—Erythema—Estradiol—prostate cancer	0.000457	0.00285	CcSEcCtD
Sufentanil—Tachycardia—Conjugated Estrogens—prostate cancer	0.000455	0.00283	CcSEcCtD
Sufentanil—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000452	0.00282	CcSEcCtD
Sufentanil—Cardiac arrest—Capecitabine—prostate cancer	0.00045	0.0028	CcSEcCtD
Sufentanil—Urinary retention—Capecitabine—prostate cancer	0.00045	0.0028	CcSEcCtD
Sufentanil—Dizziness—Bicalutamide—prostate cancer	0.000447	0.00279	CcSEcCtD
Sufentanil—Hypotension—Goserelin—prostate cancer	0.00044	0.00274	CcSEcCtD
Sufentanil—Chills—Mitoxantrone—prostate cancer	0.000439	0.00274	CcSEcCtD
Sufentanil—Arrhythmia—Mitoxantrone—prostate cancer	0.000437	0.00272	CcSEcCtD
Sufentanil—Hypotension—Conjugated Estrogens—prostate cancer	0.000435	0.00271	CcSEcCtD
Sufentanil—Vomiting—Bicalutamide—prostate cancer	0.00043	0.00268	CcSEcCtD
Sufentanil—Rash—Bicalutamide—prostate cancer	0.000426	0.00266	CcSEcCtD
Sufentanil—Dermatitis—Bicalutamide—prostate cancer	0.000426	0.00266	CcSEcCtD
Sufentanil—Erythema—Mitoxantrone—prostate cancer	0.000426	0.00265	CcSEcCtD
Sufentanil—Headache—Bicalutamide—prostate cancer	0.000424	0.00264	CcSEcCtD
Sufentanil—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000421	0.00262	CcSEcCtD
Sufentanil—Somnolence—Goserelin—prostate cancer	0.000418	0.00261	CcSEcCtD
Sufentanil—Bronchospasm—Docetaxel—prostate cancer	0.000416	0.00259	CcSEcCtD
Sufentanil—Somnolence—Conjugated Estrogens—prostate cancer	0.000414	0.00258	CcSEcCtD
Sufentanil—Pruritus—Ethinyl Estradiol—prostate cancer	0.000404	0.00252	CcSEcCtD
Sufentanil—Bronchospasm—Capecitabine—prostate cancer	0.000402	0.00251	CcSEcCtD
Sufentanil—Urinary tract disorder—Etoposide—prostate cancer	0.000402	0.0025	CcSEcCtD
Sufentanil—Nausea—Bicalutamide—prostate cancer	0.000402	0.0025	CcSEcCtD
Sufentanil—Cardiac arrest—Prednisone—prostate cancer	0.000401	0.0025	CcSEcCtD
Sufentanil—Urethral disorder—Etoposide—prostate cancer	0.000399	0.00249	CcSEcCtD
Sufentanil—Hypertension—Estradiol—prostate cancer	0.000395	0.00246	CcSEcCtD
Sufentanil—Feeling abnormal—Goserelin—prostate cancer	0.000388	0.00242	CcSEcCtD
Sufentanil—Dizziness—Ethinyl Estradiol—prostate cancer	0.000378	0.00236	CcSEcCtD
Sufentanil—Confusional state—Estradiol—prostate cancer	0.000376	0.00234	CcSEcCtD
Sufentanil—Anaphylactic shock—Estradiol—prostate cancer	0.000373	0.00232	CcSEcCtD
Sufentanil—Body temperature increased—Goserelin—prostate cancer	0.000372	0.00232	CcSEcCtD
Sufentanil—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000368	0.0023	CcSEcCtD
Sufentanil—Hypertension—Mitoxantrone—prostate cancer	0.000368	0.00229	CcSEcCtD
Sufentanil—Chills—Etoposide—prostate cancer	0.000365	0.00228	CcSEcCtD
Sufentanil—Tachycardia—Estradiol—prostate cancer	0.000364	0.00227	CcSEcCtD
Sufentanil—Vomiting—Ethinyl Estradiol—prostate cancer	0.000363	0.00227	CcSEcCtD
Sufentanil—Rash—Ethinyl Estradiol—prostate cancer	0.00036	0.00225	CcSEcCtD
Sufentanil—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00036	0.00224	CcSEcCtD
Sufentanil—Headache—Ethinyl Estradiol—prostate cancer	0.000358	0.00223	CcSEcCtD
Sufentanil—Confusional state—Mitoxantrone—prostate cancer	0.00035	0.00218	CcSEcCtD
Sufentanil—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000348	0.00217	CcSEcCtD
Sufentanil—Hypersensitivity—Goserelin—prostate cancer	0.000347	0.00216	CcSEcCtD
Sufentanil—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000343	0.00214	CcSEcCtD
Sufentanil—Nausea—Ethinyl Estradiol—prostate cancer	0.00034	0.00212	CcSEcCtD
Sufentanil—Tachycardia—Mitoxantrone—prostate cancer	0.000339	0.00211	CcSEcCtD
Sufentanil—Urinary tract disorder—Docetaxel—prostate cancer	0.000334	0.00208	CcSEcCtD
Sufentanil—Bradycardia—Capecitabine—prostate cancer	0.000333	0.00208	CcSEcCtD
Sufentanil—Pruritus—Goserelin—prostate cancer	0.000333	0.00207	CcSEcCtD
Sufentanil—Somnolence—Estradiol—prostate cancer	0.000332	0.00207	CcSEcCtD
Sufentanil—Urethral disorder—Docetaxel—prostate cancer	0.000331	0.00207	CcSEcCtD
Sufentanil—Pruritus—Conjugated Estrogens—prostate cancer	0.00033	0.00205	CcSEcCtD
Sufentanil—Hypotension—Mitoxantrone—prostate cancer	0.000325	0.00202	CcSEcCtD
Sufentanil—Urinary tract disorder—Capecitabine—prostate cancer	0.000323	0.00201	CcSEcCtD
Sufentanil—Urethral disorder—Capecitabine—prostate cancer	0.000321	0.002	CcSEcCtD
Sufentanil—Cardiac arrest—Epirubicin—prostate cancer	0.000314	0.00195	CcSEcCtD
Sufentanil—Dizziness—Goserelin—prostate cancer	0.000311	0.00194	CcSEcCtD
Sufentanil—Somnolence—Mitoxantrone—prostate cancer	0.000309	0.00193	CcSEcCtD
Sufentanil—Dizziness—Conjugated Estrogens—prostate cancer	0.000308	0.00192	CcSEcCtD
Sufentanil—Feeling abnormal—Estradiol—prostate cancer	0.000307	0.00192	CcSEcCtD
Sufentanil—Hypertension—Etoposide—prostate cancer	0.000306	0.00191	CcSEcCtD
Sufentanil—Chills—Docetaxel—prostate cancer	0.000303	0.00189	CcSEcCtD
Sufentanil—Arrhythmia—Docetaxel—prostate cancer	0.000302	0.00188	CcSEcCtD
Sufentanil—Vomiting—Goserelin—prostate cancer	0.000299	0.00186	CcSEcCtD
Sufentanil—Bradycardia—Prednisone—prostate cancer	0.000297	0.00185	CcSEcCtD
Sufentanil—Rash—Goserelin—prostate cancer	0.000297	0.00185	CcSEcCtD
Sufentanil—Dermatitis—Goserelin—prostate cancer	0.000296	0.00185	CcSEcCtD
Sufentanil—Vomiting—Conjugated Estrogens—prostate cancer	0.000296	0.00185	CcSEcCtD
Sufentanil—Body temperature increased—Estradiol—prostate cancer	0.000295	0.00184	CcSEcCtD
Sufentanil—Headache—Goserelin—prostate cancer	0.000295	0.00184	CcSEcCtD
Sufentanil—Erythema—Docetaxel—prostate cancer	0.000294	0.00183	CcSEcCtD
Sufentanil—Rash—Conjugated Estrogens—prostate cancer	0.000294	0.00183	CcSEcCtD
Sufentanil—Chills—Capecitabine—prostate cancer	0.000294	0.00183	CcSEcCtD
Sufentanil—Dermatitis—Conjugated Estrogens—prostate cancer	0.000294	0.00183	CcSEcCtD
Sufentanil—Arrhythmia—Capecitabine—prostate cancer	0.000292	0.00182	CcSEcCtD
Sufentanil—Headache—Conjugated Estrogens—prostate cancer	0.000292	0.00182	CcSEcCtD
Sufentanil—Confusional state—Etoposide—prostate cancer	0.000291	0.00182	CcSEcCtD
Sufentanil—Cardiac arrest—Doxorubicin—prostate cancer	0.00029	0.00181	CcSEcCtD
Sufentanil—Anaphylactic shock—Etoposide—prostate cancer	0.000289	0.0018	CcSEcCtD
Sufentanil—Feeling abnormal—Mitoxantrone—prostate cancer	0.000286	0.00178	CcSEcCtD
Sufentanil—Erythema—Capecitabine—prostate cancer	0.000285	0.00178	CcSEcCtD
Sufentanil—Tachycardia—Etoposide—prostate cancer	0.000282	0.00176	CcSEcCtD
Sufentanil—Nausea—Goserelin—prostate cancer	0.000279	0.00174	CcSEcCtD
Sufentanil—Nausea—Conjugated Estrogens—prostate cancer	0.000277	0.00173	CcSEcCtD
Sufentanil—Hypersensitivity—Estradiol—prostate cancer	0.000275	0.00171	CcSEcCtD
Sufentanil—Body temperature increased—Mitoxantrone—prostate cancer	0.000275	0.00171	CcSEcCtD
Sufentanil—Hypotension—Etoposide—prostate cancer	0.00027	0.00168	CcSEcCtD
Sufentanil—Pruritus—Estradiol—prostate cancer	0.000264	0.00164	CcSEcCtD
Sufentanil—Arrhythmia—Prednisone—prostate cancer	0.000261	0.00162	CcSEcCtD
Sufentanil—Somnolence—Etoposide—prostate cancer	0.000257	0.0016	CcSEcCtD
Sufentanil—Hypersensitivity—Mitoxantrone—prostate cancer	0.000256	0.0016	CcSEcCtD
Sufentanil—Hypertension—Docetaxel—prostate cancer	0.000254	0.00158	CcSEcCtD
Sufentanil—Erythema—Prednisone—prostate cancer	0.000254	0.00158	CcSEcCtD
Sufentanil—Dizziness—Estradiol—prostate cancer	0.000247	0.00154	CcSEcCtD
Sufentanil—Hypertension—Capecitabine—prostate cancer	0.000246	0.00153	CcSEcCtD
Sufentanil—Confusional state—Docetaxel—prostate cancer	0.000242	0.00151	CcSEcCtD
Sufentanil—Anaphylactic shock—Docetaxel—prostate cancer	0.00024	0.0015	CcSEcCtD
Sufentanil—Feeling abnormal—Etoposide—prostate cancer	0.000238	0.00148	CcSEcCtD
Sufentanil—Vomiting—Estradiol—prostate cancer	0.000237	0.00148	CcSEcCtD
Sufentanil—Rash—Estradiol—prostate cancer	0.000235	0.00147	CcSEcCtD
Sufentanil—Dermatitis—Estradiol—prostate cancer	0.000235	0.00146	CcSEcCtD
Sufentanil—Confusional state—Capecitabine—prostate cancer	0.000235	0.00146	CcSEcCtD
Sufentanil—Tachycardia—Docetaxel—prostate cancer	0.000234	0.00146	CcSEcCtD
Sufentanil—Headache—Estradiol—prostate cancer	0.000234	0.00146	CcSEcCtD
Sufentanil—Bradycardia—Epirubicin—prostate cancer	0.000232	0.00145	CcSEcCtD
Sufentanil—Body temperature increased—Etoposide—prostate cancer	0.000229	0.00142	CcSEcCtD
Sufentanil—Tachycardia—Capecitabine—prostate cancer	0.000227	0.00141	CcSEcCtD
Sufentanil—Urinary tract disorder—Epirubicin—prostate cancer	0.000225	0.0014	CcSEcCtD
Sufentanil—Hypotension—Docetaxel—prostate cancer	0.000224	0.0014	CcSEcCtD
Sufentanil—Urethral disorder—Epirubicin—prostate cancer	0.000224	0.00139	CcSEcCtD
Sufentanil—Nausea—Estradiol—prostate cancer	0.000222	0.00138	CcSEcCtD
Sufentanil—Vomiting—Mitoxantrone—prostate cancer	0.000221	0.00138	CcSEcCtD
Sufentanil—Hypertension—Prednisone—prostate cancer	0.000219	0.00137	CcSEcCtD
Sufentanil—Rash—Mitoxantrone—prostate cancer	0.000219	0.00137	CcSEcCtD
Sufentanil—Dermatitis—Mitoxantrone—prostate cancer	0.000219	0.00136	CcSEcCtD
Sufentanil—Headache—Mitoxantrone—prostate cancer	0.000218	0.00136	CcSEcCtD
Sufentanil—Hypotension—Capecitabine—prostate cancer	0.000217	0.00135	CcSEcCtD
Sufentanil—Bradycardia—Doxorubicin—prostate cancer	0.000215	0.00134	CcSEcCtD
Sufentanil—Somnolence—Docetaxel—prostate cancer	0.000214	0.00133	CcSEcCtD
Sufentanil—Hypersensitivity—Etoposide—prostate cancer	0.000213	0.00133	CcSEcCtD
Sufentanil—Urinary tract disorder—Doxorubicin—prostate cancer	0.000208	0.0013	CcSEcCtD
Sufentanil—Anaphylactic shock—Prednisone—prostate cancer	0.000207	0.00129	CcSEcCtD
Sufentanil—Urethral disorder—Doxorubicin—prostate cancer	0.000207	0.00129	CcSEcCtD
Sufentanil—Nausea—Mitoxantrone—prostate cancer	0.000206	0.00129	CcSEcCtD
Sufentanil—Chills—Epirubicin—prostate cancer	0.000205	0.00128	CcSEcCtD
Sufentanil—Pruritus—Etoposide—prostate cancer	0.000205	0.00127	CcSEcCtD
Sufentanil—Fentanyl—CYP3A4—prostate cancer	0.000204	0.0809	CrCbGaD
Sufentanil—Arrhythmia—Epirubicin—prostate cancer	0.000204	0.00127	CcSEcCtD
Sufentanil—Tachycardia—Prednisone—prostate cancer	0.000202	0.00126	CcSEcCtD
Sufentanil—Erythema—Epirubicin—prostate cancer	0.000199	0.00124	CcSEcCtD
Sufentanil—Feeling abnormal—Docetaxel—prostate cancer	0.000198	0.00123	CcSEcCtD
Sufentanil—Feeling abnormal—Capecitabine—prostate cancer	0.000192	0.00119	CcSEcCtD
Sufentanil—Dizziness—Etoposide—prostate cancer	0.000191	0.00119	CcSEcCtD
Sufentanil—Body temperature increased—Docetaxel—prostate cancer	0.00019	0.00118	CcSEcCtD
Sufentanil—Chills—Doxorubicin—prostate cancer	0.000189	0.00118	CcSEcCtD
Sufentanil—Arrhythmia—Doxorubicin—prostate cancer	0.000189	0.00117	CcSEcCtD
Sufentanil—Body temperature increased—Capecitabine—prostate cancer	0.000184	0.00115	CcSEcCtD
Sufentanil—Vomiting—Etoposide—prostate cancer	0.000184	0.00115	CcSEcCtD
Sufentanil—Erythema—Doxorubicin—prostate cancer	0.000184	0.00114	CcSEcCtD
Sufentanil—Rash—Etoposide—prostate cancer	0.000182	0.00114	CcSEcCtD
Sufentanil—Dermatitis—Etoposide—prostate cancer	0.000182	0.00113	CcSEcCtD
Sufentanil—Headache—Etoposide—prostate cancer	0.000181	0.00113	CcSEcCtD
Sufentanil—Hypersensitivity—Docetaxel—prostate cancer	0.000177	0.0011	CcSEcCtD
Sufentanil—Nausea—Etoposide—prostate cancer	0.000172	0.00107	CcSEcCtD
Sufentanil—Hypertension—Epirubicin—prostate cancer	0.000171	0.00107	CcSEcCtD
Sufentanil—Hypersensitivity—Capecitabine—prostate cancer	0.000171	0.00107	CcSEcCtD
Sufentanil—Feeling abnormal—Prednisone—prostate cancer	0.000171	0.00106	CcSEcCtD
Sufentanil—Pruritus—Docetaxel—prostate cancer	0.00017	0.00106	CcSEcCtD
Sufentanil—Pruritus—Capecitabine—prostate cancer	0.000165	0.00103	CcSEcCtD
Sufentanil—Body temperature increased—Prednisone—prostate cancer	0.000164	0.00102	CcSEcCtD
Sufentanil—Confusional state—Epirubicin—prostate cancer	0.000163	0.00102	CcSEcCtD
Sufentanil—Anaphylactic shock—Epirubicin—prostate cancer	0.000162	0.00101	CcSEcCtD
Sufentanil—Dizziness—Docetaxel—prostate cancer	0.000159	0.00099	CcSEcCtD
Sufentanil—Hypertension—Doxorubicin—prostate cancer	0.000159	0.000988	CcSEcCtD
Sufentanil—Tachycardia—Epirubicin—prostate cancer	0.000158	0.000986	CcSEcCtD
Sufentanil—Dizziness—Capecitabine—prostate cancer	0.000154	0.000959	CcSEcCtD
Sufentanil—Vomiting—Docetaxel—prostate cancer	0.000153	0.000952	CcSEcCtD
Sufentanil—Hypersensitivity—Prednisone—prostate cancer	0.000153	0.000951	CcSEcCtD
Sufentanil—Rash—Docetaxel—prostate cancer	0.000151	0.000944	CcSEcCtD
Sufentanil—Hypotension—Epirubicin—prostate cancer	0.000151	0.000944	CcSEcCtD
Sufentanil—Dermatitis—Docetaxel—prostate cancer	0.000151	0.000943	CcSEcCtD
Sufentanil—Confusional state—Doxorubicin—prostate cancer	0.000151	0.000942	CcSEcCtD
Sufentanil—Headache—Docetaxel—prostate cancer	0.000151	0.000938	CcSEcCtD
Sufentanil—Anaphylactic shock—Doxorubicin—prostate cancer	0.00015	0.000934	CcSEcCtD
Sufentanil—Vomiting—Capecitabine—prostate cancer	0.000148	0.000922	CcSEcCtD
Sufentanil—Rash—Capecitabine—prostate cancer	0.000147	0.000914	CcSEcCtD
Sufentanil—Pruritus—Prednisone—prostate cancer	0.000147	0.000914	CcSEcCtD
Sufentanil—Dermatitis—Capecitabine—prostate cancer	0.000147	0.000913	CcSEcCtD
Sufentanil—Tachycardia—Doxorubicin—prostate cancer	0.000146	0.000912	CcSEcCtD
Sufentanil—Headache—Capecitabine—prostate cancer	0.000146	0.000908	CcSEcCtD
Sufentanil—Somnolence—Epirubicin—prostate cancer	0.000144	0.000898	CcSEcCtD
Sufentanil—Nausea—Docetaxel—prostate cancer	0.000143	0.000889	CcSEcCtD
Sufentanil—Hypotension—Doxorubicin—prostate cancer	0.00014	0.000873	CcSEcCtD
Sufentanil—Nausea—Capecitabine—prostate cancer	0.000138	0.000861	CcSEcCtD
Sufentanil—Dizziness—Prednisone—prostate cancer	0.000137	0.000854	CcSEcCtD
Sufentanil—Feeling abnormal—Epirubicin—prostate cancer	0.000134	0.000832	CcSEcCtD
Sufentanil—Somnolence—Doxorubicin—prostate cancer	0.000133	0.000831	CcSEcCtD
Sufentanil—Vomiting—Prednisone—prostate cancer	0.000132	0.000821	CcSEcCtD
Sufentanil—Rash—Prednisone—prostate cancer	0.000131	0.000814	CcSEcCtD
Sufentanil—Dermatitis—Prednisone—prostate cancer	0.000131	0.000813	CcSEcCtD
Sufentanil—Headache—Prednisone—prostate cancer	0.00013	0.000809	CcSEcCtD
Sufentanil—Body temperature increased—Epirubicin—prostate cancer	0.000128	0.000798	CcSEcCtD
Sufentanil—Feeling abnormal—Doxorubicin—prostate cancer	0.000124	0.00077	CcSEcCtD
Sufentanil—Nausea—Prednisone—prostate cancer	0.000123	0.000767	CcSEcCtD
Sufentanil—Hypersensitivity—Epirubicin—prostate cancer	0.000119	0.000744	CcSEcCtD
Sufentanil—Body temperature increased—Doxorubicin—prostate cancer	0.000119	0.000739	CcSEcCtD
Sufentanil—Pruritus—Epirubicin—prostate cancer	0.000115	0.000714	CcSEcCtD
Sufentanil—Hypersensitivity—Doxorubicin—prostate cancer	0.00011	0.000688	CcSEcCtD
Sufentanil—Dizziness—Epirubicin—prostate cancer	0.000107	0.000668	CcSEcCtD
Sufentanil—Pruritus—Doxorubicin—prostate cancer	0.000106	0.000661	CcSEcCtD
Sufentanil—Vomiting—Epirubicin—prostate cancer	0.000103	0.000642	CcSEcCtD
Sufentanil—Rash—Epirubicin—prostate cancer	0.000102	0.000637	CcSEcCtD
Sufentanil—Dermatitis—Epirubicin—prostate cancer	0.000102	0.000636	CcSEcCtD
Sufentanil—Headache—Epirubicin—prostate cancer	0.000102	0.000633	CcSEcCtD
Sufentanil—Dizziness—Doxorubicin—prostate cancer	9.91e-05	0.000618	CcSEcCtD
Sufentanil—Nausea—Epirubicin—prostate cancer	9.63e-05	0.0006	CcSEcCtD
Sufentanil—Vomiting—Doxorubicin—prostate cancer	9.53e-05	0.000594	CcSEcCtD
Sufentanil—Rash—Doxorubicin—prostate cancer	9.45e-05	0.000589	CcSEcCtD
Sufentanil—Dermatitis—Doxorubicin—prostate cancer	9.44e-05	0.000589	CcSEcCtD
Sufentanil—Headache—Doxorubicin—prostate cancer	9.39e-05	0.000585	CcSEcCtD
Sufentanil—Nausea—Doxorubicin—prostate cancer	8.91e-05	0.000555	CcSEcCtD
Sufentanil—OPRD1—Signaling Pathways—CAV1—prostate cancer	1.57e-05	0.000191	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CXCL8—prostate cancer	1.56e-05	0.00019	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TGFBR2—prostate cancer	1.55e-05	0.000189	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ERBB3—prostate cancer	1.55e-05	0.000188	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KDR—prostate cancer	1.55e-05	0.000188	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FGFR2—prostate cancer	1.55e-05	0.000188	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HPGD—prostate cancer	1.55e-05	0.000188	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.55e-05	0.000188	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ITPR1—prostate cancer	1.53e-05	0.000186	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PIK3CB—prostate cancer	1.51e-05	0.000184	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ESR1—prostate cancer	1.51e-05	0.000184	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL2—prostate cancer	1.49e-05	0.000181	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TERT—prostate cancer	1.49e-05	0.000181	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—BAD—prostate cancer	1.48e-05	0.000179	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IGF1R—prostate cancer	1.46e-05	0.000177	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.46e-05	0.000177	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CXCL8—prostate cancer	1.45e-05	0.000177	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—JAK2—prostate cancer	1.45e-05	0.000176	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CG—prostate cancer	1.43e-05	0.000174	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—APC—prostate cancer	1.43e-05	0.000174	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HIF1A—prostate cancer	1.42e-05	0.000173	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.42e-05	0.000172	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MTAP—prostate cancer	1.42e-05	0.000172	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EGF—prostate cancer	1.41e-05	0.000172	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IRS1—prostate cancer	1.41e-05	0.000172	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—LPL—prostate cancer	1.4e-05	0.00017	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—IL2—prostate cancer	1.39e-05	0.000169	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—LEP—prostate cancer	1.39e-05	0.000169	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PDGFRB—prostate cancer	1.39e-05	0.000169	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.38e-05	0.000168	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.38e-05	0.000168	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CAV1—prostate cancer	1.38e-05	0.000167	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CB—prostate cancer	1.37e-05	0.000167	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—GSK3B—prostate cancer	1.37e-05	0.000167	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KDR—prostate cancer	1.36e-05	0.000165	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—INS—prostate cancer	1.35e-05	0.000164	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ITGB3—prostate cancer	1.35e-05	0.000164	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ESR1—prostate cancer	1.33e-05	0.000161	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CREBBP—prostate cancer	1.33e-05	0.000161	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCL8—prostate cancer	1.32e-05	0.00016	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ACSL4—prostate cancer	1.32e-05	0.00016	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.32e-05	0.00016	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ERBB3—prostate cancer	1.31e-05	0.000159	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGFR2—prostate cancer	1.31e-05	0.000159	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IGF1—prostate cancer	1.31e-05	0.000159	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—EGFR—prostate cancer	1.3e-05	0.000158	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—BAD—prostate cancer	1.29e-05	0.000157	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAP2K1—prostate cancer	1.27e-05	0.000154	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ARG2—prostate cancer	1.26e-05	0.000153	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PHGDH—prostate cancer	1.26e-05	0.000153	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—UMPS—prostate cancer	1.26e-05	0.000153	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL2—prostate cancer	1.26e-05	0.000153	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TERT—prostate cancer	1.26e-05	0.000153	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CD—prostate cancer	1.26e-05	0.000153	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—APC—prostate cancer	1.25e-05	0.000152	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CG—prostate cancer	1.25e-05	0.000152	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—PIK3CA—prostate cancer	1.25e-05	0.000151	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SERPINE1—prostate cancer	1.24e-05	0.000151	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IRS1—prostate cancer	1.24e-05	0.00015	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EGF—prostate cancer	1.24e-05	0.00015	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LDHB—prostate cancer	1.24e-05	0.00015	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—KRAS—prostate cancer	1.23e-05	0.000149	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.22e-05	0.000148	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—FGF2—prostate cancer	1.2e-05	0.000146	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—GSK3B—prostate cancer	1.2e-05	0.000146	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HIF1A—prostate cancer	1.2e-05	0.000146	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NOS3—prostate cancer	1.19e-05	0.000144	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—INS—prostate cancer	1.19e-05	0.000144	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PDHA1—prostate cancer	1.17e-05	0.000143	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—UCP3—prostate cancer	1.17e-05	0.000143	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TCN2—prostate cancer	1.17e-05	0.000143	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTA3—prostate cancer	1.17e-05	0.000143	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—LEP—prostate cancer	1.17e-05	0.000143	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CAV1—prostate cancer	1.16e-05	0.000141	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CREBBP—prostate cancer	1.16e-05	0.000141	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—JAK2—prostate cancer	1.15e-05	0.00014	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KDR—prostate cancer	1.15e-05	0.00014	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IGF1—prostate cancer	1.15e-05	0.000139	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—EGFR—prostate cancer	1.14e-05	0.000139	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PIK3CA—prostate cancer	1.13e-05	0.000137	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MDM2—prostate cancer	1.13e-05	0.000137	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ESR1—prostate cancer	1.12e-05	0.000136	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HSD3B1—prostate cancer	1.12e-05	0.000136	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC22A3—prostate cancer	1.12e-05	0.000136	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ERBB2—prostate cancer	1.11e-05	0.000135	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAP2K1—prostate cancer	1.11e-05	0.000135	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CD—prostate cancer	1.1e-05	0.000134	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CB—prostate cancer	1.1e-05	0.000133	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—BAD—prostate cancer	1.09e-05	0.000133	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PIK3CA—prostate cancer	1.09e-05	0.000133	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SERPINE1—prostate cancer	1.09e-05	0.000132	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—KRAS—prostate cancer	1.08e-05	0.000131	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTA4—prostate cancer	1.07e-05	0.00013	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TBXAS1—prostate cancer	1.07e-05	0.00013	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APC—prostate cancer	1.06e-05	0.000129	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CG—prostate cancer	1.06e-05	0.000129	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FGF2—prostate cancer	1.06e-05	0.000128	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCL8—prostate cancer	1.05e-05	0.000128	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EGF—prostate cancer	1.05e-05	0.000127	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IRS1—prostate cancer	1.05e-05	0.000127	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTA2—prostate cancer	1.05e-05	0.000127	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NOS3—prostate cancer	1.04e-05	0.000126	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCG5—prostate cancer	1.03e-05	0.000126	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.03e-05	0.000126	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CDKN1B—prostate cancer	1.03e-05	0.000125	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—AKT1—prostate cancer	1.02e-05	0.000123	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GSK3B—prostate cancer	1.02e-05	0.000123	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—JAK2—prostate cancer	1.01e-05	0.000123	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTA1—prostate cancer	1.01e-05	0.000123	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CASP3—prostate cancer	1.01e-05	0.000122	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL2—prostate cancer	1.01e-05	0.000122	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—INS—prostate cancer	1e-05	0.000122	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL6—prostate cancer	1e-05	0.000122	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HSD3B2—prostate cancer	9.99e-06	0.000121	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTO1—prostate cancer	9.99e-06	0.000121	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NAT2—prostate cancer	9.99e-06	0.000121	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PIK3CA—prostate cancer	9.92e-06	0.00012	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MDM2—prostate cancer	9.88e-06	0.00012	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CREBBP—prostate cancer	9.83e-06	0.000119	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCND1—prostate cancer	9.81e-06	0.000119	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ERBB2—prostate cancer	9.74e-06	0.000118	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CTNNB1—prostate cancer	9.72e-06	0.000118	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IGF1—prostate cancer	9.7e-06	0.000118	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—EGFR—prostate cancer	9.66e-06	0.000117	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CB—prostate cancer	9.61e-06	0.000117	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PLCB2—prostate cancer	9.58e-06	0.000116	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP2C18—prostate cancer	9.58e-06	0.000116	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LRP2—prostate cancer	9.58e-06	0.000116	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MMP9—prostate cancer	9.53e-06	0.000116	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CDKN1A—prostate cancer	9.49e-06	0.000115	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PTEN—prostate cancer	9.47e-06	0.000115	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—P4HB—prostate cancer	9.39e-06	0.000114	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAP2K1—prostate cancer	9.38e-06	0.000114	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CD—prostate cancer	9.32e-06	0.000113	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—AKT1—prostate cancer	9.24e-06	0.000112	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCL8—prostate cancer	9.23e-06	0.000112	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PIK3CA—prostate cancer	9.23e-06	0.000112	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SERPINE1—prostate cancer	9.22e-06	0.000112	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC22A1—prostate cancer	9.14e-06	0.000111	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—KRAS—prostate cancer	9.12e-06	0.000111	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EP300—prostate cancer	9.03e-06	0.00011	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CDKN1B—prostate cancer	9.02e-06	0.000109	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGF2—prostate cancer	8.92e-06	0.000108	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—AKT1—prostate cancer	8.92e-06	0.000108	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SULT2A1—prostate cancer	8.9e-06	0.000108	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CASP3—prostate cancer	8.84e-06	0.000107	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL2—prostate cancer	8.83e-06	0.000107	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NOS3—prostate cancer	8.8e-06	0.000107	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SRC—prostate cancer	8.78e-06	0.000107	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL6—prostate cancer	8.78e-06	0.000107	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MED12—prostate cancer	8.76e-06	0.000106	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GNG5—prostate cancer	8.69e-06	0.000105	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCND1—prostate cancer	8.6e-06	0.000104	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—VEGFA—prostate cancer	8.55e-06	0.000104	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—JAK2—prostate cancer	8.55e-06	0.000104	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CTNNB1—prostate cancer	8.52e-06	0.000103	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—STAT3—prostate cancer	8.47e-06	0.000103	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CA—prostate cancer	8.38e-06	0.000102	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NCOA3—prostate cancer	8.37e-06	0.000102	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MMP9—prostate cancer	8.35e-06	0.000101	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MDM2—prostate cancer	8.35e-06	0.000101	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CDKN1A—prostate cancer	8.32e-06	0.000101	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PTEN—prostate cancer	8.3e-06	0.000101	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ERBB2—prostate cancer	8.23e-06	9.99e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CB—prostate cancer	8.12e-06	9.86e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—AKT1—prostate cancer	8.1e-06	9.83e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HPGDS—prostate cancer	7.99e-06	9.69e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP2C19—prostate cancer	7.94e-06	9.63e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EP300—prostate cancer	7.92e-06	9.61e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MYC—prostate cancer	7.87e-06	9.55e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TGFB1—prostate cancer	7.85e-06	9.53e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCL8—prostate cancer	7.8e-06	9.47e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ACHE—prostate cancer	7.75e-06	9.4e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTT1—prostate cancer	7.75e-06	9.4e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SRC—prostate cancer	7.7e-06	9.35e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EGFR—prostate cancer	7.7e-06	9.34e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP2A6—prostate cancer	7.66e-06	9.29e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CDKN1B—prostate cancer	7.62e-06	9.25e-05	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—AKT1—prostate cancer	7.54e-06	9.15e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—VEGFA—prostate cancer	7.5e-06	9.1e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CASP3—prostate cancer	7.47e-06	9.07e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL2—prostate cancer	7.46e-06	9.05e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AKR1C3—prostate cancer	7.45e-06	9.04e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—STAT3—prostate cancer	7.43e-06	9.01e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL6—prostate cancer	7.42e-06	9.01e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PRKACB—prostate cancer	7.41e-06	8.99e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP17A1—prostate cancer	7.33e-06	8.9e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KRAS—prostate cancer	7.27e-06	8.83e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCND1—prostate cancer	7.27e-06	8.83e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CTNNB1—prostate cancer	7.2e-06	8.74e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MMP9—prostate cancer	7.06e-06	8.57e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CDKN1A—prostate cancer	7.03e-06	8.54e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PTEN—prostate cancer	7.02e-06	8.52e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NCOA2—prostate cancer	6.99e-06	8.48e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MYC—prostate cancer	6.9e-06	8.38e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TGFB1—prostate cancer	6.88e-06	8.36e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AKT1—prostate cancer	6.85e-06	8.31e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EGFR—prostate cancer	6.75e-06	8.19e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EP300—prostate cancer	6.69e-06	8.12e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CA—prostate cancer	6.68e-06	8.11e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC5A5—prostate cancer	6.67e-06	8.09e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP2E1—prostate cancer	6.51e-06	7.9e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SRC—prostate cancer	6.51e-06	7.9e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TP53—prostate cancer	6.46e-06	7.84e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NQO1—prostate cancer	6.44e-06	7.81e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KRAS—prostate cancer	6.38e-06	7.74e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TH—prostate cancer	6.34e-06	7.7e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—VEGFA—prostate cancer	6.34e-06	7.69e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—STAT3—prostate cancer	6.28e-06	7.62e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP1B1—prostate cancer	6.17e-06	7.49e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GGT1—prostate cancer	5.98e-06	7.25e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6—prostate cancer	5.92e-06	7.18e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NCOA1—prostate cancer	5.89e-06	7.15e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CA—prostate cancer	5.86e-06	7.11e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MYC—prostate cancer	5.83e-06	7.08e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TGFB1—prostate cancer	5.82e-06	7.06e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP19A1—prostate cancer	5.8e-06	7.04e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EGFR—prostate cancer	5.7e-06	6.92e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TP53—prostate cancer	5.67e-06	6.88e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—RXRA—prostate cancer	5.6e-06	6.8e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AKT1—prostate cancer	5.46e-06	6.62e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—COMT—prostate cancer	5.39e-06	6.55e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KRAS—prostate cancer	5.39e-06	6.54e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTP1—prostate cancer	5.37e-06	6.52e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ITPR1—prostate cancer	5.28e-06	6.41e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6—prostate cancer	5.19e-06	6.3e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TYMS—prostate cancer	4.99e-06	6.06e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CA—prostate cancer	4.95e-06	6.01e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTM1—prostate cancer	4.93e-06	5.99e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LPL—prostate cancer	4.84e-06	5.88e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TP53—prostate cancer	4.79e-06	5.81e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AKT1—prostate cancer	4.79e-06	5.81e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP1A1—prostate cancer	4.68e-06	5.68e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ERCC2—prostate cancer	4.64e-06	5.63e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6—prostate cancer	4.38e-06	5.32e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MTHFR—prostate cancer	4.36e-06	5.29e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PPARA—prostate cancer	4.28e-06	5.19e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AKT1—prostate cancer	4.04e-06	4.91e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CAV1—prostate cancer	4.02e-06	4.88e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.66e-06	4.45e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—INS—prostate cancer	3.47e-06	4.21e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CREBBP—prostate cancer	3.4e-06	4.12e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CD—prostate cancer	3.22e-06	3.91e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NOS3—prostate cancer	3.04e-06	3.69e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.81e-06	3.41e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PTGS2—prostate cancer	2.78e-06	3.38e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PTEN—prostate cancer	2.43e-06	2.94e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—EP300—prostate cancer	2.31e-06	2.81e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.71e-06	2.08e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AKT1—prostate cancer	1.4e-06	1.7e-05	CbGpPWpGaD
